title: [HIV protease inhibitors. A new drug class in antiretroviral therapy].
authors.affiliation: Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universität Düsseldorf.
authors.forename: S
authors.initials: S
authors.lastname: Mauss
authors.forename: B
authors.initials: B
authors.lastname: Seidlitz
authors.forename: H
authors.initials: H
authors.lastname: Jablonowski
authors.forename: D
authors.initials: D
authors.lastname: Häussinger
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D009705:Nucleosides / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D019258:Saquinavir / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D009705:Nucleosides; D019469:Indinavir; D019258:Saquinavir; D019438:Ritonavir
vernacular_title: HIV-Proteaseinhibitoren. Eine neue Substanzklasse in der antiretroviralen Therapie.